Key Drivers
- Margin Expansion
- High Leverage
- Negative Free Cash Flow
AIAI Summary
ARE is a leveraged life-science real-estate recovery play—not a dependable income REIT—where differentiated campuses and a 0.59x book-value valuation offer upside only if leasing and biotech funding recover before costly debt, 2027 lease rollovers, and capital-intensive development further pressure FFO and free cash flow.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin Expansion
- •High Leverage
- •Negative Free Cash Flow
ARE's operating performance is improving, but persistent losses, heavy debt, negative free cash flow, and weak dividend coverage make the apparent below-book valuation risky.
Price Behavior
Key Price Behavior Insights:
- •Recovery Holding
- •$54 Resistance
- •$51 Support
ARE remains cautiously bullish over the last month above its ~$52.43 average, but needs to reclaim $54.00 to target $56.34 while a break below $51.10 would weaken the recovery.
Sharp 5.4% drop from $56.34 to $53.30 signals near-term selling pressure
Sentiment & News
Key News Insights:
- •Institutional Accumulation
- •Leasing Headwinds
- •Q3 Catalyst
Institutional buying signals confidence in ARE, but oversupply, lease risks, and a dividend cut keep the outlook cautious ahead of Q3 results.
Near-term sentiment remains mixed, with institutional support offset by material operating and market risks
Similar Companies in Real Estate
Other companies in the same sector with AI ratings